Does BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS Cause Flatulence? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Flatulence have been filed in association with BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS. This represents 4.0% of all adverse event reports for BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS.
7
Reports of Flatulence with BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS
4.0%
of all BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS reports
0
Deaths
2
Hospitalizations
How Dangerous Is Flatulence From BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS?
Of the 7 reports, 2 (28.6%) required hospitalization.
Is Flatulence Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS Cause?
Nausea (139)
Anaemia (132)
Headache (132)
Pyrexia (132)
Constipation (128)
Pain (128)
Erythema (127)
Female genital tract fistula (127)
Oral candidiasis (126)
Proctitis (126)
What Other Drugs Cause Flatulence?
ADALIMUMAB (1,651)
POLYETHYLENE GLYCOL 3350 (1,207)
VEDOLIZUMAB (949)
SEMAGLUTIDE (925)
TIRZEPATIDE (918)
LENALIDOMIDE (865)
NINTEDANIB (832)
DULAGLUTIDE (754)
OCTREOTIDE (699)
APREMILAST (617)
Which BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS Alternatives Have Lower Flatulence Risk?
BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BILASTINE
BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BIMATOPROST
BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BIMATOPROST\TIMOLOL
BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BIMEKIZUMAB
BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BIMEKIZUMAB-BKZX